Lindbrook Capital’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.2K | Sell |
158
-133
| -46% | -$1.01K | ﹤0.01% | 2413 |
|
|
2024
Q4 | $3.54K | Sell |
291
-28
| -9% | -$341 | ﹤0.01% | 2123 |
|
|
2024
Q3 | $5.34K | Buy |
319
+28
| +10% | +$469 | ﹤0.01% | 1986 |
|
|
2024
Q2 | $5.08K | Hold |
291
| – | – | ﹤0.01% | 1985 |
|
|
2024
Q1 | $4.96K | Hold |
291
| – | – | ﹤0.01% | 1893 |
|
|
2023
Q4 | $2.97K | Buy |
+291
| New | +$2.97K | ﹤0.01% | 2119 |
|
|
2023
Q3 | – | Sell |
-154
| Closed | -$1.66K | – | 2710 |
|
|
2023
Q2 | $1.66K | Sell |
154
-233
| -60% | -$2.51K | ﹤0.01% | 2223 |
|
|
2023
Q1 | $3.96K | Buy |
387
+2
| +0.5% | +$20 | ﹤0.01% | 1953 |
|
|
2022
Q4 | $4.06K | Buy |
385
+207
| +116% | +$2.18K | ﹤0.01% | 1926 |
|
|
2022
Q3 | $2K | Hold |
178
| – | – | ﹤0.01% | 2015 |
|
|
2022
Q2 | $2K | Buy |
178
+33
| +23% | +$371 | ﹤0.01% | 1925 |
|
|
2022
Q1 | $2K | Buy |
+145
| New | +$2K | ﹤0.01% | 1958 |
|